• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

PQX1:GR

1.239 EUR 0.020 1.59%

As of 03:00:25 ET on 04/17/2014.

Snapshot for Biotage AB (PQX1)

Open: 1.231 Day's Range: 1.231 - 1.243 Volume: 0
Previous Close: 1.259 52wk Range: 0.936 - 1.271 1-Yr Rtn: +19.02%

Stock Chart for PQX1

No chart data available.
  • PQX1:GR 1.239
  • 1D
  • 1M
  • 1Y
1.259
Interactive PQX1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PQX1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.9474
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 0.6300
Est. PEG Ratio -
Market Cap (M EUR) 86.56
Shares Outstanding (M) 69.86
30 Day Average Volume 367
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 5.31%
Cash Dividend (SEK) 0.6000
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PQX1

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for PQX1

Biotage AB focuses on life sciences research. The Company provides technologies and solutions in the areas of genetic analysis and medicinal chemistry. Biotage's customers include pharmaceutical companies, biotech companies, and academic institutes. The Company has offices in several European countries, the United States, and Japan.

Ove Henning MattssonChairmanTorben JorgensenPresident/CEO
Lars BackmanVP:Corp DevelopmentErika Soderberg JohnsonChief Financial Officer
More Company Profile & Key Executives for PQX1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil